Carvana Co.: Garcia sells $33.6m in CVNA stock

Ernest C. Garcia II, a ten percent owner of Carvana (CVNA), sold over $33.5 million in Class A Common Stock on July 23-24, 2025, following a substantial 150% stock return over the past year. This significant insider sale occurs amidst widespread analyst optimism, with firms like Citi, Stephens, JPMorgan, and Citizens JMP raising price targets and maintaining positive ratings, citing robust unit sales growth and a stable automotive market for the $44.8 billion company.

Analysis

A significant insider sale at Carvana Co. (CVNA) presents a conflicting signal against a backdrop of strong stock performance and bullish analyst sentiment. Ernest C. Garcia II, a ten percent owner, liquidated over $33.5 million in stock between July 23 and July 24, 2025, an action that typically raises investor concern. However, this sale follows a 150% surge in the stock's value over the past year, suggesting the transaction could be interpreted as profit-taking. This view is reinforced by the simultaneous conversion of 50,000 Class A Units into common stock by the same insider. The prevailing Wall Street consensus remains overwhelmingly positive, with multiple analysts upgrading price targets. Citi raised its target to $415, citing 40% year-over-year unit sales growth in Q2, while Stephens and JPMorgan followed with targets of $375 and $350, respectively, forecasting robust growth and a Q3 EBITDA of approximately $570 million. The company's fundamental health appears solid, evidenced by a perfect Piotroski Score of 9. With the next earnings report due in just four days, the market is positioned for a significant data release that will either validate the high expectations set by analysts or lend more weight to the insider's decision to sell.

Key Decisions for Investors

• Consider the $33.5M insider sale as potential profit-taking or portfolio rebalancing, given the stock's 150% annual gain and the owner's simultaneous conversion of other units, rather than a purely bearish signal on fundamentals.
• The upcoming earnings report in four days is a critical catalyst; investors should scrutinize Q2 unit sales and Q3 EBITDA guidance to verify if they meet the high expectations set by recent analyst upgrades.
• Given the strong analyst price targets ($350-$440) but significant recent share appreciation, it may be prudent to hold existing positions while being prepared for volatility around the earnings announcement.
• Monitor whether the reported financials continue to support the perfect Piotroski Score of 9, as this indicator of strong financial health is a key pillar of the current bullish thesis.